Why isn't anyone using Way-316606? If it works then it grows a full head of hair back on most people Treatment 3/1/2025
Way-316606 is considered a potential hair loss treatment but is avoided due to safety concerns and lack of research. Minoxidil and Finasteride are preferred as established treatments.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity The DEFINITIVE cure for hairloss
The conversation humorously suggests using immunosuppressants like ciclosporine and oral minoxidil for hair regrowth, with a satirical plan involving hair transplants from family members. It highlights the side effects and impracticality of such treatments, emphasizing the post's satirical nature.
community 19 Y/O with Rapidly Progressing MPB – Unsure About Minoxidil & Long-Term Plan
A 19-year-old is experiencing rapidly progressing male pattern baldness and is unsure whether to start Minoxidil now or wait until they can access Finasteride. They currently use Ketoconazole shampoo and are concerned about the long-term commitment and potential shedding associated with Minoxidil.
community Hair loss transformation 14-18 yrs old
The user shared their hair loss transformation and treatment routine, which includes dutasteride, finasteride, various forms of minoxidil, and other topical treatments. They emphasized consistency in their regimen and offered to answer questions about their experience.
community Forgotten 'Total Revival' Stack
Cyclosporine A is discussed as a powerful hair growth stimulant, potentially more effective than minoxidil, but concerns about safety and side effects, including cancer risk, limit its use. The conversation highlights the need for further research and experimentation with topical application, despite its risks.
community The final nail in the coffin. PP405 is confirmed JXL069.
PP405 and JXL069 are confirmed to be the same molecule, leading to disappointment due to poor hair regrowth results. Users express skepticism about the credibility of Pelage and the effectiveness of JXL069.
Related Research
6 / 6 resultsresearch A review of the treatment of male pattern hair loss
This review discusses pharmacologic and non-pharmacologic treatments for androgenetic alopecia, noting that current medications like finasteride and minoxidil can slow hair loss but only partially restore hair growth, with early treatment offering better outcomes.
research Advances in hair growth
This review discusses recent advances in understanding hair growth mechanisms and reviews current and emerging therapies, but it presents no new clinical results.
research Molecular Mechanisms and Targeted Therapeutics in Androgenetic Alopecia: From Signaling Pathways to Regenerative Approaches
This review examines androgenetic alopecia, detailing its causes and current treatments, but reports no new clinical results; the authors emphasize understanding its complexity for personalized therapy development.
research Identifying novel strategies for treating human hair loss disorders: Cyclosporine A suppresses the Wnt inhibitor, SFRP1, in the dermal papilla of human scalp hair follicles
This study demonstrates that inhibiting SFRP1 with the antagonist WAY-316606 enhances hair growth in human scalp hair follicles ex vivo by facilitating Wnt signalling.
research Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
This review synthesizes recent research to propose a precision framework for treating androgenetic alopecia and alopecia areata based on genetic insights and pathway biology, highlighting the roles of androgen-receptor signaling, immune dysregulation, and emerging therapies like regenerative medicine and AI-assisted diagnostics.
research Análise comparativa entre os tratamentos para alopecia: uma revisão sistemática
This review covers different treatment options for alopecia areata and androgenetic alopecia and emphasizes individualized treatment plans, combining pharmacological therapy with psychological support; no new clinical results are reported.